Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.


Type 1 Diabetes

What is the purpose of this trial?

Insulin treatment often causes the blood glucose levels to fall too low. The body usually responds to low blood glucose levels by releasing hormones which act against the insulin to help correct the low blood glucose levels. However, this hormone response can be altered in people with diabetes. Currently there are no therapeutic agents that can be used to improve the recovery from hypoglycemia (low blood sugar). The aim of this study is to determine whether a formoterol inhaler can be used to improve and accelerate the recovery from hypoglycemia in patients with type 1 diabetes.

Participation Guidelines

18 Years - 55 Years

Click here for detailed information about who can participate in this trial.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Yale University
August 2010
Last Updated:
June 27, 2013
Study HIC#:

Clinicaltrials.gov ID: NCT01194479